Monday, 27 February 2017
Last updated 4 hours ago
Sep 17 2012 | 1:37pm ET
A healthcare hedge fund had a second quarter it won't soon forget, jumping more than a quarter on the period.
Palo Alto Investors rose 26.2% between April and June, Insider Monkey reports. The surge is thanks in no small part to Palo Alto's largest holding, Onyx Pharmaceuticals, which makes up almost 17% of the hedge fund's portfolio and which is up 74.5% this year.
Palo Alto also profited from its stakes in Cyberonics Inc.